Aim To explore whether killer cell immunoglobulin-like receptors (KIR) gene polymorphisms are associated with susceptibility to persistent hepatitis B virus (HBV) infection or HBV clearance.
Hepatitis B virus (HBV) infection, one of the major viral diseases in the word, especially in China, causes a broad spectrum of liver diseases (1) . It has been documented that there are currently about 350 million people with persistent HBV infection worldwide. Persistent HBV infection has been regarded as a multifactorial disorder relevant to virus, host age, sex, environment, and concurrent infections with the hepatitis C and D virus, and human immunodeficiency virus (HIV) (2) . Segregation analysis and twin studies strongly support the role of host genetic background in determining the course of HBV infection (3) (4) (5) . Actually, the susceptibility to infectious diseases is governed by a number of different factors, such as cytokine production, antigen presentation, and receptor recognition. Of note, genetic susceptibility to persistent HBV infection or HBV clearance are likely polygenic, pertaining to genes such as the genes of human leukocyte antigen (HLA) and class cytokine receptor.
It has been reported that killer cell immunoglobulin-like receptor (KIR) genes present diversity in the Chinese population (6, 7) . However, it is unknown whether KIR genes participate in the regulation of HBV infectious process. KIR gene family, located on human chromosome 19q13.4, encodes HLA class I receptors expressed by natural killer (NK) cells and subsets of T-cells. KIR genes are organized in a highly polymorphic, multi-gene family with considerable allelic polymorphism. The genes have been divided into distinct groups, depending on the number of external immunoglobulin domains (2D or 3D). The presence of a long cytoplasmatic tail with two immune tyrosine-based inhibitory motifs (ITIM) allows the transduction of inhibitory signals and characterizes the inhibitory KIRs (2DL, 3DL), whereas the presence of short cytoplasmatic tails corresponds to the activating KIR receptors (2DS, 3DS) (8) (9) (10) (11) . Theoretically, NK cells and T cells activation may be regulated by one of the two following mechanisms: the presence of and signaling through activating receptors on a large proportion of effector cells (ie, KIR haplotypes containing many activating receptors) or the presence of inhibitory receptor-ligand combinations that send relatively poor inhibitory signals. Upon interaction with HLA class I molecules expressed on the surface of target cells, KIR genes provide activating or suppressing signals to regulate the activation of NK cells and T cells, thereby playing an important role in antiviral and anti-tumor immunity (12) .
Previous studies have demonstrated that KIR genes are involved in the pathogenesis of a variety of diseases, including rheumatoid arthritis, vasculitis (13, 14) , psoriatic arthritis (15), type 1 diabetes mellitus (16) , and hepatitis C virus (17) . However up to now, the role of KIR polymorphisms in patients with HBV infection has not been investigated. Therefore, the present study was designed to investigate the KIR gene polymorphisms in a large cohort of 150 chronic hepatitis B patients, 251 spontaneously recovered cases, and 412 healthy controls by means of sequence specific primer polymerase chain reaction (SSP-PCR), with special attention given to the relationship between KIRs and the HBV infection or HBV clearance.
Methods

Study subjects
The 813 samples analyzed for this study comprised 150 samples from patients with chronic hepatitis B (CHB), 251 spontaneously recovered (SR) controls, and 412 healthy unrelated adult Chinese recruited from Shandong Provincial Hospital and Jinan Infectious Disease Hospital, both in Jinan, between October 2004 and August 2006. CHB patients were required to have a history of hepatitis B viral infection for more than one year and elevated levels of alanine aminotransferase/aspartate aminotransferase or total bilirubin when recruited. Those who were negative for hepatitis B surface antigen (HBsAg) and positive for both hepatitis B surface antibody (HBsAb) and hepatitis B core antibody (HBcAb) were defined as SR controls. All the recruited subjects had no serological evidence of hepatitis C virus, hepatitis D virus, and HIV coinfection; they had no diabetes, malignant tumor, or any autoimmune diseases (18) . All studies were performed after informed consent was obtained from the subjects.
Research approach
Genome DNA extraction. Genomic DNA sample was extracted from 5mL EDTA (EDTA) anticoagulated peripheral blood with a standard salting-out procedure and stored at -20°C before use.
Genotyping with SSP-PCR method. KIR genotyping was performed by the sequencespecific primer polymerase chain reaction (SSP-PCR) method in all the recruited subjects. KIR locus typing was performed to detect the presence or absence of a total of 14 KIR loci and one pseudogene KIRZ. Among them, 8 KIR genes (2DLI, 2DL2, 2DL3, 2DL4, 2DL5, 3DL1,3DL2, and 3DL3) were responsible for inhibitory functions and 6 KIR genes (2DS1, 2DS2, 2DS3, 2DS4, 2DS5, and 3DS1) for conveying activating signals. The SSP-PCR primers used for the detection of KIR loci were based on primer sites that have been previously described (15) . Among the 29 formatted couple primers (Shanghai BoYa biotechnology Co.Ltd, Shangai, China), 2DS5 gene uses one couple primer and each of the 14 surplus genes uses two couple primers, so as to ensure a detectable rate of positive gene (KIR genes primer in Table   Table 1 . Sequence specific polymerase chain reaction (PCR) primers of killer cell immunoglobulin-like receptors (KIR) genes TCA TGT TTG AA  GGT CCC TGC CAG GTC TTG CG  127  TGG ACC AAG AGT CTG CAG GA  TGT TGT CTC CCT AGA AGA CG  330  2DL2  CTG GCC CAC CCA GGT CG  GGA CCG ATG GAG AAG TTG GCT  173  GAG GGG GAG GCC CAT GAA T  TCG AGT TTG ACC ACT CGT AT  150  2DL3  CTT CAT CGC TGG TGC TG  AGG CTC TTG GTC CAT TAC AA  550  TCC TTC ATC GCT GGT GCT G  GGC AGG AGA CAA CTT TGG ATC A  800  2DL4  CAG GAC AAG CCC TTC TGC  CTG GGT GCC GAC CAC T  254  ACC TTC GCT TAC AGC CCG  GGG TTT CCT GTG ACA GAA ACA G  288  2DL5  GCG CTG TGG TGC CTC G  GAC CAC TCA ATG GGG GAG C  214  TGC AGC TCC AGG AGC TCA  GGG TCT GAC CAC TCA TAG GGT  194  3DL1  CGC TGT GGT GCC TCG A  GGT GTG AAC CCC GAC ATG  197  CCC TGG TGA AAT CAG GAG AGA G  TGT AGG TCC CTG CAA GGG CAA  181  3DL2  CAA ACC CTT CCT GTC TGC CC  GTG CCG ACC ACC CAG TGA  245  CCC ATG AAC GTA GGC TCC G  CAC ACG CAG GGC AGG G  130  3DL3  GTC AGA TGT CAG GTT TGA GCG  CAT GGA ATA GTT GAC CTG GGA AC  112  GCA GCT CCC GGA GCT TG  GGG TCT GAC CAC GCG TG  190  2DS1  CTTCTCCATCAGTCGCATGAA  CTTCTCCATCAGTCGCATGAG  102  CTTCTCCATCAGTCGCATGAA  AGAGGGTCACTGGGAGCTGAC  102  2DS2  TTC TGC ACA GAG AGG GGA AGT A  AGG TCA CTG GGA GCT GAC AA  173  CGG GCC CCA CGG TTT  GGT CAC TCG AGT TTG ACC ACT CA  240  2DS3  TGG CCC ACC CAG GTC G  TGA AAA CTG ATA GGG GGA GTG AGG  242  CTA TGA CAT GTA CCA TCT ATC CAC  AAG CAG TGG GTC ACT TGA C  190  2DS4  CTG GCC CTC CCA GGT CA  TCT GTA GGT TCC TGC AAG GAC AG  204  CTG GCC CTC CCA GGT CA  GGA ATG TTC CGT TGA TGC  2000  2DS5  TGA TGG GGT CTC CAA GGG  TCC AGA GGG TCA CTG GGC  125  3DS1  AGC CTG CAG GGA ACA GAA G  GCC TGA CTG TGG TGC TCG  300  CCT GGT GAA ATC AGG AGA GAG  GTC CCT GCA AGG GCA C  177  2DP1  GTC TGC CTG GCC CAG CT  GTG TGA ACC CCG ACA TCT GTA C  205  CCA TCG GTC CCA TGA TGG CAC TGG GAG CTG ACA ACT GAT G 90 1 Agarose gel electrophoreses and image scanning. The PCR products, together with approximately 3µL 100 base pairs (bp) DNA ladder as molecular weight marker (MBI, San Francisco, CA, USA), were electrophoresed on 1.5% agarose gels with bromophenol blue, keeping voltage at 160 V for 30 minutes. After electrophoresis, the agarose gel was scanned and imaged by Alphaimager TM 2200 instrument (Alpha Innotech Corporation, San Leandro, CA, USA) and each sample was genotyped. A result of electrophoresis of the KIR genes PCR products is shown in Figure 1 . All primers were validated to be gene-specific by PCR product sequencing.
Statistical analysis
The phenotype frequency (pf, %) of each KIR was calculated as the percentage of positive numbers among all specimens. Genotype frequency (gf) was calculated with the formula gf = 1-
. KIR genotype frequency (gf) differences were tested for significance by two-tailed Fisher exact test or χ 2 test. Analyses were performed by the SAS 9.0 statistical package (SAS, Cary, NC, USA).
Results
In this study, all the tested KIR genes were present in both patient groups and control group in different frequencies. Framework genes KIR2DL4, KIR3DL2, KIR3DL3, and KIRZ were present in all individuals (Table 2) .
KIR phenotype and genotype frequency in patients and control subjects
The total carriage frequency of KIR2DL5, KIR2DS2, KIR2DS3, and KIR2DS5 was higher in CHB patients than in health control subjects (P = 0.001, P = 0.001, P = 0.011, and P = 0.028, respectively).
The total carriage frequency of KIR2DS2 and KIR2DS3 was higher (P = 0.001, P = 0.014, respectively), while the frequency of KIR2DL5, KIR2DS1, and KIR3DS1 was lower (P = 0.001, P = 0.001, and P = 0.001, respectively) in CHB patients than in SR controls. As for KIR2DS5, there was no significant difference between these two groups (P = 0.605).
The total carriage frequency of KIR2DL5, KIR2DS1, KIR2DS5, and KIR3DS1 in SR controls was significantly higher than in healthy controls (P<0.001, P<0.001, P<0.001, and P<0.001, respectively). There was no significant difference in the frequency of KIR2DS2 and KIR2DS3 between the two groups (P = 0.526, P = 0.919, respectively) (Table 2, Figure 2 ).
Activating KIRs in healthy controls and SR controls
We divided SR and healthy controls into 2 groups as follows: group one with a single activating KIR gene and group two with 2 or more activating KIR genes. Out of 251 SR controls, only 56 were in the group one and 195 in the group two (22.31% and 77.69%, respectively). On the contrary, the percentage in healthy controls was 66.26% and 33.74%, respectively.
Discussion
Our data clearly showed that there was a difference in the frequencies of these KIR genes in three different sets of subjects. To date, most of the studies on human genes relevant to HBV infection have focused on HLA genetic alteration. For example, genetic association analyses based on Gambian, European, and Asian cohorts have implicated the role of HLA allele DRB1*1302 in the clearance of HBV infection (21-23). As KIR molecules modulate cell function upon the recognition of HLA class I, it can be inferred that KIR gene may also exert a crucial role in the pathogenesis of HBV infection. In the present study, we analyzed 15 known KIR genes in CHB, SR control, and healthy control group. We found that the frequencies of KIR2DS2 and KIR2DS3 in CHB patients were significantly higher than in normal controls, but not in SR controls, indicating that the two genes may serve as HBV infectious susceptibility genes. *Abbreviations: + -positive case numbers; PC -P value for the comparison between chronic hepatitis group and healthy control group; PS -P value for the comparison between spontaneously recovered group and healthy control group; P -P-value for the comparison between spontaneously recovered group and chronic hepatitis group.
Recent evidence has suggested that a subset of T cells expressing KIR2DS2 can mediate vascular damage in patients with rheumatoid arthritis, implicating a role of activating KIR in rheumatoid arthritis (16) and other autoimmune diseases (14) . Although the samples used in this study were different, our results were, at least in part, in agreement with these findings. This suggests that KIR2DS2 is involved in inflammatory reaction and also that the excessive inflammatory reaction leads to liver tissue damage. Clinically, HBV infection does not invariably result in chronic hepatitis since the host possesses the ability to eliminate the virus spontaneously in most cases. It is believed that the antibody response to viral envelope antigens contributes to clearance of the virus and that cytotoxic T cells mediate viral clearance by killing the infected cells. In addition, one study has shown that cytotoxic T lymphocytes inhibit HBV gene expression through the secretion of antiviral cytokines and that the expression of these cytokines may be the principal mechanism of viral clearance during HBV infection (24) . It is hypothesized that chronic infection is related to a weak T-cell response to viral antigens. Recent research has demonstrated that KIRs expressed on the cell surface of NK and T cells play a role in the regulation of innate and acquired anti-virus immune responses through the transduction of inhibitory or activating signals (11, 19, 20) . In CHB, the excessive expression of KIR2DS2 and KIR2DS3 may weakly activate NK or T cells' cytotoxicity and regulate it, leading to deferrable and persistent destruction of the hepatocytes. KIR2DS2 and KIR2DS3 are observed in high positive linkage disequilibrium (25) , which might be a reason for the simultaneous increase of both of them.
To further analyze our data according to the number of activating KIRs and inhibitory KIRs, we found that there was a significant difference in the two kinds of KIRs between SR controls and healthy control group (Table 2, Figure 2 ). This may mean that, in SR patients, more activating KIRs send more activating signals to NK cells or to T cells, resulting in HBV clearance or recruitment of other cells of the immune system.
In this study, both the activating KIR2DS1, KIR3DS1 and the inhibitory KIR2DL5 were higher in SR patients than in healthy controls and CHB patients. So, we suggested that these KIR genes may play a role in the clearance of HBV.
In conclusion, our results implicate that KIR2DS2 and KIR2DS3 may act as HBV susceptive genes to induce a persistent weak inflammatory reaction that results in continuous injury of live tissues and chronic hepatitis; whereas, KIR2DS1, KIR3DS1, and KIR2DL5 may be protective genes that facilitate the clearance of HBV.
